entity

microglial_activation

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about microglial_activation: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

192Connections

9Hypotheses

30Analyses

50Outgoing

50Incoming

0Experiments

20Debates

No AI portrait yet

Outgoing (58)

Target	Relation	Type	Str
alzheimers	implicated_in	disease	0.95
alzheimer_disease	associated_with	disease	0.95
sepsis-associated encephalopathy	contributes_to	unknown	0.90
synaptic_engulfment	causes	pathological_process	0.90
alzheimer_disease	involved_in	disease	0.90
neurodegeneration	involved_in	disease	0.90
alzheimers	involved_in	disease	0.90
neuroinflammation	causes	phenotype	0.90
frontotemporal dementia	involved_in	disease	0.90
oxidative_stress	causes	phenotype	0.90
pro-inflammatory cytokines release	causes	unknown	0.90
phagocytosis	contributes_to	mechanism	0.90
mitochondrial DNA release	causes	mechanism	0.88
alzheimer_disease	implicated_in	disease	0.85
neurotoxicity	contributes_to	mechanism	0.85
alzheimer_disease	contributes_to	disease	0.85
phagocytosis	modulates	mechanism	0.85
alzheimers	biomarker_for	disease	0.85
phagocytosis	mediates	mechanism	0.85
alzheimers	contributes_to	disease	0.85
synapse loss	associated_with	phenotype	0.85
TDP-43	involved_in	protein	0.85
neurodegeneration	contributes_to	disease	0.82
neuron loss	contributes_to	unknown	0.80
oxidative_stress	increases_risk	phenotype	0.80
phagocytosis	involved_in	mechanism	0.80
neurodegeneration	associated_with	disease	0.80
alzheimers	associated_with	disease	0.80
neurodegeneration	modulates	disease	0.80
brain homeostasis	modulates	unknown	0.80
neuropathological process	associated_with	unknown	0.80
lipid_droplet_biogenesis	modulates	pathway	0.80
neurodegeneration	causes	disease	0.80
oxidative_stress	contributes_to	phenotype	0.80
neurodegeneration	mediates	disease	0.80
phagocytosis	downregulates	mechanism	0.80
oxidative_stress	mediates	phenotype	0.75
glymphatic_clearance	contributes_to	mechanism	0.75
glymphatic_clearance	associated_with	mechanism	0.75
TDP-43_aggregation	associated_with	phenotype	0.75
white_matter_lesions	contributes_to	unknown	0.75
NAD+ depletion	contributes_to	mechanism	0.75
Tau Propagation	regulates	phenotype	0.70
synaptic pruning	regulates	phenotype	0.70
gray_matter_atrophy	contributes_to	unknown	0.70
alzheimers	increases_risk	disease	0.70
neuroinflammatory injury	causes	phenotype	0.70
Alzheimer's_disease	associated_with	disease	0.70
mitochondrial_transfer	associated_with	mechanism	0.70
glymphatic_clearance	modulates	mechanism	0.70

Incoming (134)

Source	Relation	Type	Str
fibrinogen_deposition	triggers_via_CD18	process	0.00
APOE4	inhibits	protein	0.95
neurodegeneration	associated_with	disease	0.95
neuroinflammation	associated_with	mechanism	0.95
TREM2_protein	regulates	protein	0.95
brain_aging	associated_with	unknown	0.95
mitochondrial DAMPs	associated_with	gene	0.90
GPR109A	regulates	gene	0.90
glucose_metabolism	regulates	unknown	0.90
NAD+ depletion	contributes_to	mechanism	0.90
TREM1	activates	unknown	0.90
BACH1	modulates	unknown	0.90
lipid_droplet_biogenesis	causes	pathway	0.90
rTMS	inhibits	unknown	0.90
NF-κB	activates	pathway	0.90
SPP1	activates	protein	0.90
oxidative_stress	causes	phenotype	0.90
Trem2	regulates	protein	0.90
APOE4	regulates	protein	0.90
mitochondrial dysfunction	contributes_to	mechanism	0.90
mutant THAP11	causes	unknown	0.90
GPR32	modulates	protein	0.85
TREM2	mediates	gene	0.85
HK2	modulates	protein	0.85
alzheimer_disease	associated_with	disease	0.85
TREM2_protein	involved_in	protein	0.85
HK2	involved_in	protein	0.85
oxidative stress	contributes_to	mechanism	0.85
sleep_deprivation	causes	phenotype	0.85
NAD+ depletion	causes	mechanism	0.85
beta-amyloid	causes	unknown	0.85
adolescent alcohol consumption	causes	unknown	0.85
TREM2_protein	mediates	protein	0.85
traumatic_brain_injury	causes	unknown	0.85
APOE4	modulates	protein	0.85
LXA4	inhibits	protein	0.82
APOE4	activates	protein	0.80
glycolytic_enzymes	implicated_in	unknown	0.80
mitochondrial DNA release	activates	mechanism	0.80
HEXB	causes	gene	0.80
innate immune functions	involved_in	unknown	0.80
APOE4	causes	protein	0.80
lipid_droplet_biogenesis	inhibits	pathway	0.80
phagocytosis	involved_in	mechanism	0.80
sleep_fragmentation	causes	phenotype	0.80
BMAL1	modulates	gene	0.80
LXA4	modulates	protein	0.80
mitochondrial_dysfunction	associated_with	mechanism	0.80
circadian_disruption	causes	phenotype	0.80
protein aggregation	associated_with	mechanism	0.80

Targeting Hypotheses (9)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
TREM2 Microglial Activation Rescues Amyloid Clearance in AD	0.682	neurodegeneration	Test Hypothesis Fixtures
TREM2-Independent Microglial Activation via CSF1R	0.659	neurodegeneration	Methodology challenge: dataset 'Allen Br
sex-divergent microglial activation states and X-linked immu	0.626	neurodegeneration	Sex-Specific Microglial States in Amyloi
TREM2-SYK microglial activation as a stage-specific Alzheime	0.610	neurodegeneration	Test
GluN2B-Mediated Microglial Activation and Tau Propagation	0.565	neuroscience	Circuit-level neural dynamics in neurode

Temporal NLRP3 Inhibition During SPP1-Driven Microglial Acti	0.551	neuroinflammation	What molecular mechanisms mediate SPP1-i
CSF1R Agonism for TREM2-Independent Microglial Activation in	0.445	neurodegeneration	Test
GluN2B-Mediated Microglial Activation and Tau Phagocytosis	0.380	neuroscience	Circuit-level neural dynamics in neurode
Timed Melatonin Administration Exploits Circadian Vulnerabil	0.000	-	Microglia-astrocyte crosstalk amplificat

Mentioning Analyses (30)

Scientific analyses that reference this entity

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

neurodegeneration | 2026-04-28 | 7 hypotheses Top: 0.662

What blood-brain barrier permeability changes serve as early biomarkers for neur

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.745

What mechanisms drive the self-amplifying vicious cycle linking oxidative stress

neurodegeneration | 2026-04-25 | 6 hypotheses Top: 0.760

Microglial subtypes in neurodegeneration — friend vs foe

neurodegeneration | 2026-04-17 | 7 hypotheses Top: 0.685

Analyze the spectrum of microglial activation states (DAM, homeostatic, inflamma

neurodegeneration | 2026-04-17 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (8)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649]	Zhang J, St Pierre Schneider B, Muguerza	Am J Physiol Endocrinol Metab	2026
Interplay between CD33 and TREM2 in Alzheimer's Disease: Potential Mechanistic I [PMID:41388352]	["Akinluyi Elizabeth T", "Takahashi-Yama	ACS chemical neuroscience	2026
Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clear [PMID:35672148]	["Shi Qian", "Chang Cheng", "Saliba Afaf	The Journal of neuroscience :	2022
Differential vulnerability of hippocampal CA3-CA1 synapses to Aβ. [PMID:35379353]	Unknown	Acta Neuropathol Commun	2022
Discovery and engineering of an anti-TREM2 antibody to promote amyloid plaque cl [PMID:35921534]	["Zhao P", "Xu Y", "Fan X", "Li L", "Li	mAbs	2022
Tau accumulation triggers STAT1-dependent memory deficits by suppressing NMDA re [PMID:31085626]	Unknown	EMBO Rep	2019
Chronic brain inflammation causes a reduction in GluN2A and GluN2B subunits of N [PMID:24761931]	Unknown	Mol Brain	2014
Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyt [PMID:15212844]	Unknown	Neurobiol Aging	2004

Debates (20)

Multi-agent debates referencing this entity

Second debate: Microglial TREM2-SYK Pathway Enhancement

closed · Rounds: 4 · Score: 0.57 · 2026-04-28

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

closed · Rounds: 4 · Score: 0.76 · 2026-04-28

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

closed · Rounds: 4 · Score: 0.12 · 2026-04-27

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

closed · Rounds: 4 · Score: 0.42 · 2026-04-27

Debate: LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability i

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes

closed · Rounds: 4 · Score: 0.47 · 2026-04-27

Debate: Microglial TREM2 downregulation impairs damage-associated response in la

closed · Rounds: 4 · Score: 0.21 · 2026-04-27

Should '40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Sele

closed · Rounds: 4 · Score: 0.52 · 2026-04-27

Should 'ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matt

closed · Rounds: 4 · Score: 0.72 · 2026-04-27

What blood-brain barrier permeability changes serve as early biomarkers for neur

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

Related Research

Hypotheses and analyses mentioning microglial_activation in their description or question text

Temporal NLRP3 Inhibition During SPP1-Driven Microglial Activation Windows

Score: 0.551 · neuroinflammation · 2026-04-20

## Mechanistic Overview Temporal NLRP3 Inhibition During SPP1-Driven Microglial Activation Windows starts from the claim

CSF1R Agonism for TREM2-Independent Microglial Activation in ALS

Score: 0.445 · neurodegeneration · 2026-05-10

Proposed CSF1R agonism to activate neuroprotective microglial states avoiding TREM2-dependent inflammation. Fatal mechan

GluN2B-Mediated Microglial Activation and Tau Phagocytosis

Score: 0.380 · neuroscience · 2026-04-27

This hypothesis proposes that GluN2B-containing NMDA receptors on microglia directly regulate tau protein clearance thro

Timed Melatonin Administration Exploits Circadian Vulnerability of Microglial Ac

Score: 0.000 · unknown disease · 2026-04-28

Since microglial IL-1α/TNF production follows circadian rhythms, precisely timed high-dose melatonin administration duri

microglial_activation

Understanding Entity Pages

Outgoing (58)

Incoming (134)

Targeting Hypotheses (9)

Mentioning Analyses (30)

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

What blood-brain barrier permeability changes serve as early biomarkers for neur

What mechanisms drive the self-amplifying vicious cycle linking oxidative stress

Microglial subtypes in neurodegeneration — friend vs foe

Analyze the spectrum of microglial activation states (DAM, homeostatic, inflamma

Analyze the spectrum of microglial activation states (DAM, homeostatic, inflamma

Gut Microbiome Analysis in Parkinson's Disease

Does TRPML1 enhancement cause therapeutic benefit or paradoxical lysosomal dysfu

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

What molecular mechanisms enable Gal3 to enhance tau fibrillation upon binding t

Can TREM2 receptor switching from agonism to antagonism be achieved safely witho

Does reduced Prevotellaceae abundance cause PD pathology or result from it?

What brain concentrations of SCFAs are achieved via oral probiotics and are they

Do circadian disruptions cause neurodegeneration or result from it?

Why do clinical manifestations overlap despite distinct underlying etiologies in

How does SPI1 transcriptionally regulate C1QA and C1QC expression in atheroscler

Can circadian interventions reverse microglial priming independent of sleep disr

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pa

Neuroinflammation and microglial priming in early AD

Neuroinflammation and microglial priming in early Alzheimer's Disease

Tau propagation mechanisms and therapeutic interception points

SEA-AD Single-Cell Analysis: Cell-Type Vulnerability in Alzheimer's Disease

How do neurodegeneration gene expression patterns in SEA-AD differ from other po

Which cell types show the most significant expression changes for neurodegenerat

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

Cell type vulnerability in Alzheimers Disease (SEA-AD transcriptomic data)

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Cell type vulnerability in Alzheimer's Disease (SEA-AD data - v2)

Microglial subtypes in neurodegeneration — friend vs foe

TREM2 Therapeutic Strategy Post-INVOKE-2

Experiments (0)

Related Papers (8)

Debates (20)

Second debate: Microglial TREM2-SYK Pathway Enhancement

Methodology challenge: dataset 'Allen Brain SEA-AD Single Cell Dataset' — evalua

Debate: LPCAT3-Mediated Lands Cycle Remodeling as the Primary Ferroptotic Primin

Debate: ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE P

Debate: LPCAT3-Mediated Lands Cycle Amplification of Ferroptotic Vulnerability i

Debate: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes

Debate: Microglial TREM2 downregulation impairs damage-associated response in la

Should '40 Hz Gamma Entrainment Gates ACSL4-Mediated Ferroptotic Priming to Sele

Should 'ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drives White Matt

What blood-brain barrier permeability changes serve as early biomarkers for neur

Related Research

Temporal NLRP3 Inhibition During SPP1-Driven Microglial Activation Windows

CSF1R Agonism for TREM2-Independent Microglial Activation in ALS

GluN2B-Mediated Microglial Activation and Tau Phagocytosis

Timed Melatonin Administration Exploits Circadian Vulnerability of Microglial Ac